Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis

Tabibian, James H., O'Hara, Steven P., Trussoni, Christy E., Tietz, Pamela S., Splinter, Patrick L., Mounajjed, Taofic, Hagey, Lee R., LaRusso, Nicholas F.·2016·Hepatology
DOI 10.1002/hep.27927

Cited by (224)

Items 101–200 of 224

  1. Human bile microbiota: A retrospective study focusing on age and gender
    Nicola Serra, Paola Di Carlo, Francesco D’Arpa, Emanuele Onofrio Battaglia, Teresa Fasciana, Gaspare Gulotta, Carmelo Massimo Maida, Vito Rodolico, Anna Giammanco, Consolato Maria Sergi · 2021 · Journal of Infection and Public Health
  2. Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies
    Emanuele Rinninella, Pauline Celine Raoul, Marco Cintoni, Marta Palombaro, Gabriele Pulcini, Antonio Gasbarrini, Maria Cristina Mele · 2021 · Microorganisms
  3. Gut Microbiota Modulation: A Viable Strategy to Address Medical Needs in Hepatocellular Carcinoma and Liver Transplantation
    Ze Xiang, Jian Wu, Jiarui Li, Shusen Zheng, Xuyong Wei, Xiao Xu · 2023 · Engineering
  4. Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling
    Shengmin Yan, Bilon Khambu, Xiaoyun Chen, Zheng Dong, Grace Liejun Guo, Xiao‐Ming Yin · 2020 · Cellular and Molecular Gastroenterology and Hepatology
  5. Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review
    Xinpei Gu, Qin Lu, Chengcheng Zhang, Zhewei Tang, Liuxi Chu · 2021 · Seminars in Liver Disease
  6. Bile Acids and Biliary Fibrosis
    Sayed Obaidullah Aseem, Phillip B. Hylemon, Huiping Zhou · 2023 · Cells
  7. Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts
    Burcin Özdirik, Bernd Schnabl · 2023 · Cellular and Molecular Gastroenterology and Hepatology
  8. Novel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis
    Marco Sciveres, Silvia Nastasio, Giuseppe Maggiore · 2019 · Frontiers in Pediatrics
  9. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value
    Zhen-Jiao Li, Hong-Zhong Gou, Yulin Zhang, Xiaojing Song, Lei Zhang · 2022 · World Journal of Gastroenterology
  10. Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b
    Konstantina Kyritsi, Fanyin Meng, Tianhao Zhou, Nan Wu, Julie K Venter, Heather Francis, Lindsey Leann Kennedy, Paolo Onori, Antonio Franchitto, Francesca Bernuzzi et al. · 2017 · American Journal Of Pathology
  11. Review article: next‐generation transformative advances in the pathogenesis and management of autoimmune hepatitis
    Albert J. Czaja · 2017 · Alimentary Pharmacology & Therapeutics
  12. Host microbiota dictates the proinflammatory impact of LPS in the murine liver
    Su Suriguga, Theerut Luangmonkong, Henricus A. M. Mutsaers, Geny M. M. Groothuis, Peter Olinga · 2020 · Toxicology in Vitro
  13. Primary sclerosing cholangitis and inflammatory bowel disease: Intestine–liver interrelation
    Paulina Núñez F, Rodrigo Quera P., Fernando Gomollón · 2019 · Gastroenterología y Hepatología (English Edition)
  14. Roles of Trained Immunity in the Pathogenesis of Cholangiopathies: A Therapeutic Target
    Yan, Chao, Koda, Stephane, Wu, Jing, Zhang, Bei‐Bei, Yu, Qian, Netea, Mihai G., Tang, Ren‐Xian, Zheng, Kui‐Yang · 2020 · Hepatology
  15. Immunobiology of primary sclerosing cholangitis
    Cornillet, Martin, Geanon, Daniel, Bergquist, Annika, Björkström, Niklas K. · 2025 · Hepatology
  16. Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor Deficiency Promotes the Ductular Reaction, Macrophage Accumulation, and Hepatic Fibrosis in the Abcb4 Mouse
    Anuradha Krishnan, Tomohiro Katsumi, Maria Eugenia Guicciardi, Adiba I. Azad, Nazlı Begüm Öztürk, Christy E. Trussoni, Gregory James Gores · 2020 · American Journal Of Pathology
  17. Role of the Gut–Liver Axis in the Pathobiology of Cholangiopathies: Basic and Clinical Evidence
    Maria Consiglia Bragazzi, Rosanna Venere, Anthony Vignone, Domenico Alvaro, Vincenzo Cardinale · 2023 · International Journal of Molecular Sciences
  18. Colangitis esclerosante primaria y enfermedad inflamatoria intestinal: interrelación intestino-hígado
    Paulina Núñez F, Rodrigo Quera, Fernando Gomollón · 2019 · Gastroenterología y Hepatología
  19. Yinzhihuang formula modulates the microbe‒gut‒liver axis and bile acid excretion to attenuate cholestatic liver injury
    Xin Luo, Peng Cheng, Yuan Fang, Feihui Wang, Ting Mao, Yunlong Shan, Yin Lu, Zhonghong Wei · 2025 · Phytomedicine
  20. Etiopathogenesis and Diagnostic Strategies in Autoimmune Hepatitis
    Weronika Domerecka, Anna Kowalska-Kępczyńska, Agata Michalak, Iwona Homa‐Mlak, Radosław Mlak, Halina Cichoż‐Lach, Teresa J Malecka-Massalska · 2021 · Diagnostics
  21. Update on pharmacotherapies for cholestatic liver disease
    Ahmad Hassan Ali, James H. Tabibian, Keith D. Lindor · 2016 · Hepatology Communications
  22. Role of the Intestinal Microbiome in Cholestatic Liver Disease
    Nicholas F. LaRusso, James H. Tabibian, Steven P. O’Hara · 2017 · Digestive Diseases
  23. Relationship between Intestinal Microflora and Hepatocellular Cancer Based on Gut‐Liver Axis Theory
    Shipeng Li, Wenfeng Han, Qichen He, Wei Zhang, Youcheng Zhang · 2022 · Contrast Media & Molecular Imaging
  24. Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition
    Esther Verkade, Wenqiang Shen, Milaine V. Hovingh, Niels L. Mulder, Krisztina de Bruyn, Martijn Koehorst, Hilde D. de Vries, Vincent W. Bloks, Folkert Kuipers, Jan Freark de Boer · 2023 · Clinical Science
  25. The gut-liver axis in hepatobiliary diseases
    Masataka Ichikawa, Haruka Okada, Nobuhiro Nakamoto, Nobuhito Taniki, Po–Sung Chu, Takanori Kanai∥ · 2024 · Inflammation and Regeneration
  26. Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype
    Mandy Sowa, Rafał Kolenda, Daniel C. Baumgart, Johann Pratschke, Mária Papp, Tamás Tornai, Jarosław Suchański, Dimitrios Petrou Bogdanos, Maria G. Mytilinaiou, Jutta Hammermann et al. · 2018 · Frontiers in Immunology
  27. Attenuated fibrosis in specific pathogen‐free microbiota in experimental cholestasis‐ and toxin‐induced liver injury
    Sheida Moghadamrad, Mohsin Hassan, Kathy D. McCoy, Jorum Kirundi, Philipp Kellmann, Andrea De Gottardi · 2019 · The FASEB Journal
  28. Therapeutic Opportunities of GPBAR1 in Cholestatic Diseases
    Fangling Zhang, Xiaolin Xiao, Yong Li, Hefei Wu, Xinyu Deng, Yinxiao Jiang, Wenwen Zhang, Jian Wang, Xiao Ma, Yanling Zhao · 2022 · Frontiers in Pharmacology
  29. Bile Duct Diseases
    Yoh Zen, Stefan G. Hübscher, Yasuni Nakanuma · 2017 · Elsevier eBooks
  30. Gut microbial alterations in neonatal jaundice pre- and post-treatment
    Juan Ding, Xiao Ma, Liping Han, Xianlan Zhao, Ang Li, Xin Qi, Weining Lian, Zhen Li, Hongyan Ren, Zhigang Ren · 2021 · Bioscience Reports
  31. Gut microbiome in liver pathophysiology and cholestatic liver disease
    Shengmin Yan, Xiao‐Ming Yin · 2021 · Liver Research
  32. Emerging pharmacologic therapies for primary sclerosing cholangitis
    Angela Cheung, Konstantinos N. Lazaridis, Nicholas F. LaRusso, Gregory James Gores · 2017 · Current Opinion in Gastroenterology
  33. Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management
    Albert J. Czaja · 2018 · Digestive Diseases and Sciences
  34. The “gut microbiota” hypothesis in primary sclerosing cholangitis
    Valerio Pontecorvi, Marco Carbone, Pietro Invernizzi · 2016 · Annals of Translational Medicine
  35. Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities
    Huiping Zhou, Yi Huang, Chen Chen, Meiyi Song, Phillip B. Hylemon · 2026 · Pharmacological Reviews
  36. Machine learning approach identifies meconium metabolites as potential biomarkers of neonatal hyperbilirubinemia
    Shujuan Zeng, Zhangxing Wang, Peng Zhang, Zhaoqing Yin, Xunbin Huang, Xisheng Tang, Lindong Shi, Kaiping Guo, Ting Liu, Mingbang Wang et al. · 2022 · Computational and Structural Biotechnology Journal
  37. Intestinal homeostasis in autoimmune liver diseases
    Qiaoyan Liu, Wei He, Ruqi Tang, Xiong Ma · 2022 · Chinese Medical Journal
  38. Absence of gut microbiota reduces neonatal survival and exacerbates liver disease in Cyp2c70-deficient mice with a human-like bile acid composition
    Wilhelm Sjöland, Annika M. Wahlstrom, Kassem Makki, Marc Schoeler, Antonio Molinaro, Lisa M. Olsson, Thomas Uwe Greiner, Robert Caesar, Jan Freark de Boer, Folkert Kuipers et al. · 2023 · Clinical Science
  39. Evolving paradigm of treatment for autoimmune hepatitis
    Albert J. Czaja · 2017 · Expert Review of Clinical Immunology
  40. Alterations in gut microbiota and metabolite profiles in patients with infantile cholestasis
    Meng Jin, Jinghua Cui, Hui-Juan Ning, Meijuan Wang, Wenwen Liu, Kunyu Yao, Jing Yuan, Xuemei Zhong · 2023 · BMC Microbiology
  41. Mucosal immunity in primary sclerosing cholangitis: from the bowel to bile ducts and back again
    Evaggelia Liaskou, Mohammed Nabil Quraishi, Palak Jitendrakumar Trivedi · 2022 · Current Opinion in Gastroenterology
  42. Causal associations between gut microbiota and Cholestatic liver diseases: a Mendelian randomization study
    Jiaqi Yang, Gang Ma, Kemei Wang, Hui Yang, Shuangshuang Jiang, Qingling Fan, Xinmin Zhou, Guanya Guo, Ying Han · 2024 · Frontiers in Medicine
  43. Association of gut microbiota and gut metabolites and adverse outcomes in biliary atresia: A longitudinal prospective study
    Vandana Jain, Matthew J. Dalby, Emma C Alexander, Charlotte Burford, Holly Acford-Palmer, Iliana R. Serghiou, Nancy M. Y. Teng, Raymond Kiu, Konstantinos Gerasimidis, Konstantina Zafeiropoulou et al. · 2024 · Hepatology Communications
  44. PSC and colitis: A complex relationship
    Ludwig Jesse Horst, Jan Kempski, Martine Walmsley, Samuel Huber, Christoph Schramm · 2025 · Hepatology
  45. Immunobiology of bile and cholangiocytes
    Li Yang, Patrick S.C. Leung, Weici Zhang, Shucheng Zhang, Zhenning Liu, Mark J. Kurth, Andrew D. Patterson, M. Eric Gershwin, Junmin Song · 2025 · Journal of Autoimmunity
  46. The Gut‐Liver Axis in Primary Sclerosing Cholangitis: Are Pathobionts the Missing Link?
    Steven P. O’Hara, Nicholas F. LaRusso · 2019 · Hepatology
  47. An update on treatment options for primary sclerosing cholangitis.
    Shahrokh Iravani, Arash Dooghaie Moghadam, Niloofar Razavi-Khorasani, Bobak Moazzami, Amirreza Dowlati Beirami, Alireza Mansour-Ghanaei, Keivan Majidzadeh‐A, Azim Mehrvar, Alireza Khoshdel, Mohssen Nasiri Toosi et al. · 2020 · Gastroenterology and hepatology from bed to bench.
  48. Analysis of the intestinal microbiota and profiles of blood amino acids and acylcarnitines in neonates with hyperbilirubinemia
    Junguo Li, Shenglin Ye, Xinyuan Huang, Guolong Yang, Yijin Wang, Jiang‐Hui Zeng, Chunhui Lai · 2024 · BMC Microbiology
  49. Analysis of gut microecological characteristics and differences between children with biliary atresia and non-biliary atresia in infantile cholestasis
    Yajun Liu, Yuan Zhang, Cheng Guo, Muxia Li, Ye Wang, Lin Zhang · 2024 · Frontiers in Cellular and Infection Microbiology
  50. Understanding crosstalk between the gut and liver microbiome: pathogenesis to therapeutic approaches in liver cancer
    Himanshi Goyal, Kaneez Fatima, Jyotdeep Kaur · 2025 · Cancer Cell International
  51. Characteristics of intestinal microbiota in infants with late-onset breast milk jaundice
    Qianying Guo, Xinran Liu, Mingxuan Cui, Xuening Li, Chen Yang, Shilong Zhao, Lina Pan, Xiaoyu Peng, Linlin Wang, Peng Liu · 2023 · Frontiers in Nutrition
  52. Functional roles of gut bacteria imbalance in cholangiopathies
    Keisaku Sato, Fanyin Meng, Giammarco Fava, Shannon S. Glaser, Gianfranco D. Alpini · 2018 · Liver Research
  53. Implications of gut microbiota in autoimmune liver diseases
    Qiwei Qian, Wei He, Ruqi Tang, Xiong Ma · 2021 · Minerva Gastroenterology
  54. Manipulation of the Gut-Liver Axis Using Microbiome Restoration Therapy in Primary Sclerosing Cholangitis
    Jasmohan Singh Bajaj, R. Ann Hays · 2019 · The American Journal of Gastroenterology
  55. Pharmacologic management of primary sclerosing cholangitis: what’s in the pipeline?
    Jaspreet S. Suri, Vilas R. Patwardhan, Alan Bonder · 2019 · Expert Review of Gastroenterology & Hepatology
  56. A bélflóra patofiziológai jelentősége és szerepe mint terápiás célpont májbetegségekben
    Krisztina Hagymási, Anna Bacsárdi, Anna Egresi, Evelin Berta, Zsolt Tulassay, Gabriella Lengyel · 2018 · Orvosi Hetilap
  57. Clinical Characterization of Ulcerative Colitis in Patients with Primary Sclerosing Cholangitis
    Shun Murasugi, Ayumi Ito, Teppei Omori, Shinichi Nakamura, Katsutoshi Tokushige · 2020 · Gastroenterology Research and Practice
  58. Microbiota and Alcoholic Liver Disease
    Peng Chen, Yukiko Miyamoto, Magdalena Mazagova, Kuei‐Chuan Lee, Lars Eckmann, Bernd Schnabl · 2016 · Alcoholism Clinical and Experimental Research
  59. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
    Jinyu Zhao, Ping Yue, Ningning Mi, Matu Li, Wenkang Fu, Xianzhuo Zhang, Long Gao, Mingzhen Bai, Liang Tian, Ningzu Jiang et al. · 2024 · Medical Review
  60. Ursodeoxycholic Acid Treatment in Primary Sclerosing Cholangitis
    James H. Tabibian, Keith D. Lindor · 2016 · Springer eBooks
  61. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices
    Brian M. Fung, James H. Tabibian · 2021 · Expert Review of Gastroenterology & Hepatology
  62. Intestinal microbiota in biliary diseases
    Qiyun Xia, Qiaoyan Liu, Xiong Ma · 2023 · Current Opinion in Gastroenterology
  63. Toxic bile and sclerosing cholangitis: Is there a role for pharmacological interruption of the bile acid enterohepatic circulation?
    Paul A. Dawson · 2015 · Hepatology
  64. How does the microbiome affect liver disease?
    Herbert Tilg, Christoph Grander, Alexander Rupert Moschen · 2016 · Clinical Liver Disease
  65. Autoimmune liver disease and the enteric microbiome
    Kerri L. Glassner, Eamonn M.M. Quigley, Lissa Franco, David W. Victor · 2018 · AIMS Microbiology
  66. Intrahepatic biliary strictures after liver transplantation are morphologically similar to primary sclerosing cholangitis but immunologically distinct
    Taotao Zhou, Katja Bartelheimer, Fabian Ruping, Christian Rupp, Peter Sauer, Ronald Koschny, Arianeb Mehrabi, Markus Mieth, Rebecca von Haken, Karl Heinz Weiss et al. · 2019 · European Journal of Gastroenterology & Hepatology
  67. The Potentiality of Herbal Remedies in Primary Sclerosing Cholangitis: From In Vitro to Clinical Studies
    Elisa Ceccherini, Antonella Cecchettini, Maria Aurora Morales, Silvia Rocchiccioli · 2020 · Frontiers in Pharmacology
  68. UEG Week 2016 Oral Presentations
    Johan M. Burisch, Lars Ulrik Gerdes, S Almer, Silvija Čuković‐Čavka, Shaji Sebastian, Ioannis P Kaimakliotis, Dana Ďuricová, Natalia Pedersen, Riina Salupere, Kári Rubek Nielsen et al. · 2016 · United European Gastroenterology Journal
  69. Could gut microbiota protect against sclerosing cholangitis?
    Hanns–Ulrich Marschall, Fredrik Bäckhed · 2015 · Hepatology
  70. Does the Intestinal Microbiota Explain Differences in the Epidemiology of Liver Disease between East and West?
    Nobuhiro Nakamoto, Bernd Schnabl · 2016 · Inflammatory Intestinal Diseases
  71. The Gut Microbiota and the Hepatologist: Will Our Bugs Prove to be the Missing Link?
    Mark John Pallen, Mohammed Nabil Quraishi · 2017 · Digestive Diseases
  72. Gut microbiota in PSC : From association to possible causality. Commentary to “Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis” by Nakamoto et al., Nature Microbiology, January 2019
    Sara Lemoinne, João Sabino, Harry Sokol · 2019 · Clinics and Research in Hepatology and Gastroenterology
  73. Indian National Association for Study of the Liver Guidance Document on Difficult to Treat Autoimmune Hepatitis
    Sunil Taneja, Akash Roy, Rohit Mehtani, Abraham Koshy, Ajay Jain, Akash Shukla, Amit Goel, Anil Arora, Anil C. Anand, Anoop Saraya et al. · 2026 · Journal of Clinical and Experimental Hepatology
  74. The changing faces of cholangitis
    Sum P. Lee, Joseph R. Roberts, Rahul Kuver · 2016 · F1000Research
  75. Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship
    Matteo Peviani, Nora Cazzagon, Martina Gambato, Luisa Bertin, Fabiana Zingone, Edoardo V. SAVARINO, B Barberio · 2024 · Minerva Gastroenterology
  76. Biliary stem cells in health and cholangiopathies and cholangiocarcinoma
    Vincenzo Cardinale, Savino Paradiso, Domenico Alvaro · 2024 · Current Opinion in Gastroenterology
  77. Primary and Secondary Sclerosing Cholangitis
    Christopher L. Bowlus, David N. Assis, David Goldberg · 2018 · Elsevier eBooks
  78. Gut microbiome in biliary atresia
    Vandana Jain · 2026 · World Journal of Pediatric Surgery
  79. Bile Duct Diseases
    Yoh Zen, Stefan G. Hübscher, Yasuni Nakanuma · 2023 · Elsevier eBooks
  80. Analysis of gut microbiota in rats with bile duct obstruction after biliary drainage
    Bo Zhou, Kai Chen, Haiyan Gong, Liyuan Zhao, Xinfeng Xing, Hongde Su, Yu Zhang · 2023 · Microbial Pathogenesis
  81. The Pathogenesis of Autoimmune Liver Diseases
    Alexander J. Kovalic, Herbert L. Bonkovsky · 2020 · Springer eBooks
  82. DISEASES OF THE LIVER AND INTESTINAL MICROBIOME
    Волынец Галина Васильевна, Анатолий Ильич Хавкин, Скворцова Тамара Андреевна, Artem V. Nikitin, V. V. Matkash · 2019 · Russian Pediatric Journal
  83. The gut microbiota regulates mouse biliary regenerative responses
    Wenli Liu, Chao Yan, Bo Zhang, Renjin Chen, Yu Qian, Xiangyang Li, Yuzhao Zhang, Hui Ming Hua, Yanxia Wei, Yanbo Kou et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  84. The Gut Microbiome and Liver Disease
    Le‐Xing Yu, Jasmohan Singh Bajaj, Robert F. Schwabe · 2020 · Wiley eBooks
  85. Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in PSC
    Muyiwa Awoniyi, Jeremy Wang, Billy Ngo, Vik Meadows, Jason W. Tam, Amba Viswanathan, Yunjia Lai, Stephanie A. Montgomery, Morgan Farmer, Martin Kummen et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  86. Primary sclerosing cholangitis and IgG4-associated cholangitis
    Christopher L. Bowlus · 2024 · Elsevier eBooks
  87. The gut-liver/bile axis: Gut microbiota and bacterial extracellular vesicles remodeling hepatobiliary pathogenesis
    Siyang Hu, Chunhui He, Kunqi Sun, Hongye Zhou, Xueyan Liu, Dr. Hao Wang, Sen Li, Haifeng Yu, Ke Xu, Wei Li · 2026 · iScience
  88. Synthetic receptors for steroids: from molecular recognition to biomedical functions
    Y G Liu, Qing‐Yu Zhao, Si‐Dan Guo, Kang Cai · 2026 · Chemical Society Reviews
  89. LECT2 deficiency contributes to bile acid metabolic reprogramming and cholestatic liver injury
    Wenbo Shi, Luze Cen, Jing Huang, Xinyi Lei, Ying Wang, Shan Wang, Jiayi Ying, Yuanyuan Li, Yuxia Ma, Yimeng Fang et al. · 2026 · Hepatology Communications
  90. The Microbiome and Human Disease: A New Organ of Interest in Biliary Disease
    Johannes R. Hov · 2017 · Springer eBooks
  91. Autoimmune Hepatitis and Immune-Mediated Cholestatic Liver Diseases
    Albert J. Czaja · 2018 · Springer eBooks
  92. Primary Sclerosing Cholangitis Overlapping with IBD
    João Sabino, Joren tenHove, Joana Torres · 2019 · Springer eBooks
  93. [Apolipoprotein B and small, dense LDL-C].
    Yasuki Ito · 2012 · PubMed
  94. Phospholipid complex-based microemulsion for treating concurrence of primary sclerosing cholangitis and inflammatory bowel disease via gut-liver crosstalk
    Yihao He, Ru Guo, Lu Yang, Ling Li, Tong Zhang, Bing Wang, Yongzhuo Huang · 2024 · Chinese Chemical Letters
  95. Primary Sclerosing Cholangitis
    Sharonjeet Sangha, Christopher L. Bowlus · 2008 · Humana Press eBooks
  96. Historical Overview
    Trenton R. Schoeb, Roger P. Orcutt · 2017 · Elsevier eBooks
  97. The HVEM-BTLA Immune Checkpoint Restrains Murine Chronic Cholestatic Liver Injury by Regulating the Gut Microbiota
    Yanbo Kou, Xingping Zheng, Liyuan Meng, Mengnan Liu, Shihong Xu, Qiyue Jing, Shenghan Zhang, Hanying Wang, Jinzhi Han, Zhuanzhuan Liu et al. · 2022 · Frontiers in Immunology
  98. Primary Sclerosing Cholangitis
    Christopher L. Bowlus · 2020 · Springer eBooks
  99. Ursodeoxycholic Acid in Liver Cirrhosis: A Chinese Perspective
    Wenkang Gao, Zhonglin Li, Huikuan Chu, Hang Yuan, Lilin Hu, Lin Yao, Li Rita Zhang, Weijun Wang, Rong Lin, Ling Yang · 2022 · Springer eBooks
  100. Changes in biliary microbiota before and after drainage of malignant biliary obstruction
    Jin-Liang Wu, Yan Chen, Zhi-Hua Ni, Tong-Lei Fang, Qinghua Tian, Liang-Rui Gu, Kai Yang, Xiao-Lei Huang · 2025 · Research Square